ID
13156
Description
A Randomized Study of Epigenetic Priming Using Decitabine With Front Line Induction Chemotherapy Compared With Immediate Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT00943553
Lien
https://clinicaltrials.gov/show/NCT00943553
Mots-clés
Versions (1)
- 20/01/2016 20/01/2016 -
Détendeur de droits
CC BY-NC 3.0
Téléchargé le
20 janvier 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Acute Myelogenous Leukemia (AML) NCT00943553
Eligibility Acute Myelogenous Leukemia (AML) NCT00943553
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
pregnancy or lactation
Type de données
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
CML
Type de données
boolean
Alias
- UMLS CUI [1]
- C0023474
Description
APL
Type de données
boolean
Alias
- UMLS CUI [1]
- C0023487
Description
cns leukemia
Type de données
boolean
Alias
- UMLS CUI [1]
- C1332884
Description
congenital syndromes
Type de données
boolean
Alias
- UMLS CUI [1]
- C0013080
- UMLS CUI [2]
- C0015625
- UMLS CUI [3]
- C0005859
- UMLS CUI [4]
- C1853118
- UMLS CUI [5]
- C1260899
Description
white blood cells
Type de données
boolean
Alias
- UMLS CUI [1]
- C0023508
Description
creatinine
Type de données
boolean
Alias
- UMLS CUI [1]
- C0201976
Description
bilirubin, ALT
Type de données
boolean
Alias
- UMLS CUI [1]
- C1278039
- UMLS CUI [2]
- C0201836
Description
chemotherapy, radiation
Type de données
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C1522449
Description
HIV
Type de données
boolean
Alias
- UMLS CUI [1]
- C0019682
Description
any history of or concomitant medical condition that, in the opinion of the investigator, would compromise the subject's ability to safely complete the study
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C2348563
- UMLS CUI [1,2]
- C0439801
- UMLS CUI [1,3]
- C0009488
Description
the investigator believes the subject to be medically unfit to receive the study drug or unsuitable for any other reason
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C2348563
- UMLS CUI [1,2]
- C0439801
- UMLS CUI [1,3]
- C0009488
Description
hypersensitivity to decitabine, daunorubicin, or cytarabine
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0049065
- UMLS CUI [2,1]
- C0020517
- UMLS CUI [2,2]
- C0011015
- UMLS CUI [3,1]
- C0020517
- UMLS CUI [3,2]
- C0010711
Description
has participated in a drug trial in the last 4 weeks
Type de données
boolean
Alias
- UMLS CUI [1]
- C2348568
Similar models
Eligibility Acute Myelogenous Leukemia (AML) NCT00943553
- StudyEvent: Eligibility
C0700589 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
C0015625 (UMLS CUI [2])
C0005859 (UMLS CUI [3])
C1853118 (UMLS CUI [4])
C1260899 (UMLS CUI [5])
C0201836 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,2])
C0009488 (UMLS CUI [1,3])
C0049065 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0011015 (UMLS CUI [2,2])
C0020517 (UMLS CUI [3,1])
C0010711 (UMLS CUI [3,2])